BioCentury
ARTICLE | Company News

Abbott, GlaxoSmithKline deal

December 5, 2011 8:00 AM UTC

Abbott partnered with GlaxoSmithKline to co-develop and commercialize a PCR-based companion diagnostic for GSK's PRAME ASCI (Antigen-Specific Cancer Immunotherapy) for non-small cell lung cancer (NSCL...